Home NDC 80587-182 NDC 80587-182 - Triprolidine HCl Drops This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 80587-182
Package NDCs from labels 80587-182-01
Manufacturer Prime Labs LLC dba Quality CDMO
Effective date 2025-11-19
Current FDA listing Not matched in FDA.report NDC product tables
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 8 of 36 · 719 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Droptics Performance Eye Drops NAPHAZOLINE HYDROCHLORIDE, PROPYLENE GLYCOL Droptics LLC 20fd6822-a7fd-4593-92bb-0a07260893e2 2026-02-09 Warnings Exact identifier unii: 6DC9Q167V3 Cold and Allergy D PSEUDOEPHEDRINE HCL, TRIPROLIDINE HCL Walgreen Company 832ac849-7f4a-489a-a704-9d4388a75a71 2026-02-03 Warnings Exact identifier unii: YAN7R5L890 Optase GLYCERIN Scope Health Inc 376e0289-28e9-e87f-e063-6294a90a3b04 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc 10c3e31d-779d-8ff6-e063-6294a90acd39 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc 9e96976b-2990-79e0-e053-2995a90a0f29 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc d81c1a4f-87b0-ee8c-e053-2995a90af9e5 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc f452a2c4-c869-7bf5-e053-2995a90ac1a0 2026-01-30 Warnings Exact identifier unii: PDC6A3C0OX Regener-Eyes Ophthalmic Solution LITE XL GLYCERIN OPHTHALMIC SOLUTION M & M PRODUCTS, L.L.C. 47ab9609-4291-30b2-e063-6394a90a421e 2026-01-29 Warnings Exact identifier unii: PDC6A3C0OX Regener-Eyes Ophthalmic Solution PROFESSIONAL STRENGTH XL GLYCERIN OPHTHALMIC SOLUTION M & M PRODUCTS, L.L.C. 48d6dc98-66e8-b499-e063-6394a90ae935 2026-01-29 Warnings Exact identifier unii: PDC6A3C0OX Optase GLYCERIN Scope Health Inc 86c14327-ffc7-806e-e053-2991aa0aaf92 2026-01-29 Warnings Exact identifier unii: PDC6A3C0OX Sodium Citrate and Citric Acid SODIUM CITRATE AND CITRIC ACID MONOHYDRATE Atlantic Biologicals Corp. 42d837ae-2578-46df-92d2-24774964aaad 2026-01-28 Adverse reactions Exact identifier unii: 1Q73Q2JULR unii: XF417D3PSL Regener-Eyes Ophthalmic Solution PROFESSIONAL GLYCERIN OPHTHALMIC SOLUTION M & M PRODUCTS, LLC 49771efa-6682-51d0-e063-6294a90a18a5 2026-01-28 Warnings Exact identifier unii: PDC6A3C0OX Regener-Eyes Ophthalmic Solution LITE GLYCERIN OPHTHALMIC SOLUTION M & M PRODUCTS, LLC 497763ee-dc70-bb48-e063-6294a90afb3d 2026-01-28 Warnings Exact identifier unii: PDC6A3C0OX INSULIN DILUTING MEDIUM FOR Kirsty WATER Biocon Biologics Inc. 3db1d482-7e1f-aec6-79ef-3f305b4d8277 2026-01-20 Warnings, Adverse reactions Exact identifier unii: 059QF0KO0R Artifical Tears GLYCERIN AND PROPYLENE GLYCOL Wal-Mart Stores Inc 99cfea82-afb8-4c5f-ac0c-492204a42c08 2026-01-20 Warnings Exact identifier unii: 6DC9Q167V3 unii: PDC6A3C0OX Lemon Glycerin GLYCERIN Jianerkang Medical Co., Ltd edee14da-13d8-4bc2-9c37-cfc353763d11 2026-01-16 Warnings Exact identifier unii: PDC6A3C0OX Hemorrhoidal Cream HEMORRHOIDAL CREAM Walgreens 1ac2b2ae-c090-483b-ad2c-1374552add4a 2026-01-15 Warnings Exact identifier unii: PDC6A3C0OX Walgreens Adult Glycerin Laxative GLYCERIN SUPPOSITORY Walgreens f19c6cca-e763-4c38-a546-855f027d20c5 2026-01-15 Warnings Exact identifier unii: PDC6A3C0OX Walgreens Adult Glycerin Laxative GLYCERIN SUPPOSITORY Walgreens 1a00ff43-ba79-4339-a547-f9757872958b 2026-01-15 Warnings Exact identifier unii: PDC6A3C0OX Hemorrhoidal Cream HEMORRHOIDAL CREAM Walgreens 4276ddad-2363-462a-bb97-574f946ec3f0 2026-01-15 Warnings Exact identifier unii: PDC6A3C0OX
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.